chr1-1420263-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001145210.3(ANKRD65):c.539C>T(p.Ala180Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000399 in 1,001,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145210.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD65 | NM_001145210.3 | c.539C>T | p.Ala180Val | missense_variant | 3/4 | ENST00000537107.6 | |
ANKRD65-AS1 | XR_946814.2 | n.98G>A | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD65 | ENST00000537107.6 | c.539C>T | p.Ala180Val | missense_variant | 3/4 | 5 | NM_001145210.3 | P1 | |
ANKRD65-AS1 | ENST00000428932.1 | n.19G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000204 AC: 3AN: 146768Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000117 AC: 1AN: 855098Hom.: 0 Cov.: 30 AF XY: 0.00000251 AC XY: 1AN XY: 398168
GnomAD4 genome AF: 0.0000204 AC: 3AN: 146768Hom.: 0 Cov.: 33 AF XY: 0.0000420 AC XY: 3AN XY: 71406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.539C>T (p.A180V) alteration is located in exon 3 (coding exon 2) of the ANKRD65 gene. This alteration results from a C to T substitution at nucleotide position 539, causing the alanine (A) at amino acid position 180 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at